Sunday, September 24, 2017
Sign in to Endpoints
Menu Search Chat
  • Special Reports
  • Deep Dives
  • ENDPOINTS 100
  • News
  • Protocols
  • Bioregnum
  • Thumbs Up/Down
  • About
  • Advertise
  • Privacy Policy
  • Reader center

UPDATED: Two years on, Allergan’s $1.7B NASH drug still looks weak — at best

by John Carrollenvelope — on September 22, 2017 09:58 AM EDT
Updated: 11:22 AM

AbbVie’s top execs paint a rosy pic of the mega-blockbuster future looming for Humira and PhIII drugs

by John Carrollenvelope — on September 22, 2017 07:48 AM EDT

UPDATED: House committee wants to know a lot more about the cyberattack that damaged Merck

by Arsalan Arifenvelope — on September 22, 2017 06:45 AM EDT
Updated: 09:36 AM

A China biotech unicorn scores big with $150M-plus IPO on Nasdaq, stock rockets up

by John Carrollenvelope — on September 21, 2017 08:36 AM EDT
Updated: 09:36 AM

Nestle plans to ax hundreds of R&D staffers, shutter big dermatology campus

by John Carrollenvelope — on September 21, 2017 08:05 AM EDT
Updated: 08:28 AM

Chris Garabedian’s Xontogeny shepherds its first biotech through a $10M startup round

by John Carrollenvelope — on September 21, 2017 07:30 AM EDT

Want to start fixing the gender diversity problem in your biotech company? Put down the silver bullet

by John Carrollenvelope — on September 21, 2017 06:18 AM EDT

After settling with the SEC, biotech VC Steven Burrill now faces up to 30 years for fraud, tax evasion charges

by John Carrollenvelope — on September 20, 2017 03:30 PM EDT
Updated: 03:34 PM

FDA’s Janet Woodcock: the clinical trials system is ‘broken’

by Zachary Brennan - RAPSenvelope — on September 20, 2017 02:20 PM EDT

Sanofi’s Elias Zerhouni says his R&D group is ready to stand alone — but big M&A and partnerships still loom large

by John Carrollenvelope — on September 20, 2017 09:28 AM EDT
Updated: 10:20 AM

  • 1
  • 2
  • 3
  • 80

Contact Endpoints News

You can also contact John Carroll, Editor at john@endpointsnews.com

← Go back
  • About
  • Privacy Policy
  • Media Kit

copyright 2017 Endpoints Company

Yes, I'd like to subscribe No, thanks
I'm already a subscriber
Thank you for staying with us. It's great to have you on board!
Aww, shucks. Perhaps you can tell us what we could do to make you interested in subscribing?
Sure No
← Go back

Sign in to Endpoints News

I forgot my password Request a magic link
← Go back

Request a magic link

Enter your email below to get a Magic link which lets you sign in quickly without using a password.
Please note the Magic link is one-time use only and valid for only 24 hours.
← Go back

Set a new password

We will send you a link, with which you will be able to set a new password.
Please note this link is one-time use only and valid for only 24 hours.